whether to use Arixtra instead of Lovenox for acute coronary syndrome

November 2005

Experts are debating whether to use Arixtra instead of Lovenox for acute coronary syndrome.

The latest evidence suggests Arixtra (fondaparinux) works at least as well as Lovenox (enoxaparin) to prevent ischemia, heart attack, and death. Arixtra also seems to cause fewer major bleeds.

But most experts aren't yet convinced that Arixtra is safer.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote